Last updated: February 21, 2025
Sponsor: Ain Shams University
Overall Status: Completed
Phase
3
Condition
Colic
Vomiting
Lactose Intolerance
Treatment
Dextrose 10%
ringer lactate (20ml/kg)
Clinical Study ID
NCT06847594
FMASU MS129/2024
Ages 21-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age: 21- 60 years
Patients with ASA classification I and II
Exclusion
Exclusion Criteria:
Declining to give written informed consent.
Patients with morbid obesity (BMI > 40).
ASA classification III-V.
Sever hypertension and heart failure.
Significant hepatic or renal disorder.
Patients with diagnosed diabetes mellitus type 1 or type 2.
Patients with history of PONV currently receiving steroids or antiemetics.
Pregnant or menstruating patients.
Study Design
Total Participants: 204
Treatment Group(s): 2
Primary Treatment: Dextrose 10%
Phase: 3
Study Start date:
February 25, 2024
Estimated Completion Date:
October 10, 2024
Connect with a study center
Faculty of Medicine Ain Shams University
Cairo, Abbassia 11591
EgyptSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.